132 related articles for article (PubMed ID: 31157349)
1. Frizzled-7-targeted delivery of zinc oxide nanoparticles to drug-resistant breast cancer cells.
Ruenraroengsak P; Kiryushko D; Theodorou IG; Klosowski MM; Taylor ER; Niriella T; Palmieri C; Yagüe E; Ryan MP; Coombes RC; Xie F; Porter AE
Nanoscale; 2019 Jul; 11(27):12858-12870. PubMed ID: 31157349
[TBL] [Abstract][Full Text] [Related]
2. A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells.
Shen Y; Li M; Liu T; Liu J; Xie Y; Zhang J; Xu S; Liu H
Int J Nanomedicine; 2019; 14():4029-4044. PubMed ID: 31213813
[No Abstract] [Full Text] [Related]
3. Targeted delivery of quercetin via pH-responsive zinc oxide nanoparticles for breast cancer therapy.
Sadhukhan P; Kundu M; Chatterjee S; Ghosh N; Manna P; Das J; Sil PC
Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():129-140. PubMed ID: 30948047
[TBL] [Abstract][Full Text] [Related]
4. The Anti-Breast Cancer Effects of Green-Synthesized Zinc Oxide Nanoparticles Using Carob Extracts.
Pouresmaeil V; Haghighi S; Raeisalsadati AS; Neamati A; Homayouni-Tabrizi M
Anticancer Agents Med Chem; 2021; 21(3):316-326. PubMed ID: 32698752
[TBL] [Abstract][Full Text] [Related]
5. Ameliorated
Joshi M; Bhatt P
Nanotechnology; 2024 May; 35(33):. PubMed ID: 38746972
[TBL] [Abstract][Full Text] [Related]
6. Green synthesis, formulation and biological evaluation of a novel ZnO nanocarrier loaded with paclitaxel as drug delivery system on MCF-7 cell line.
Akbarian M; Mahjoub S; Elahi SM; Zabihi E; Tashakkorian H
Colloids Surf B Biointerfaces; 2020 Feb; 186():110686. PubMed ID: 31816463
[TBL] [Abstract][Full Text] [Related]
7. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
[TBL] [Abstract][Full Text] [Related]
8. Triple stimuli-responsive ZnO quantum dots-conjugated hollow mesoporous carbon nanoplatform for NIR-induced dual model antitumor therapy.
Feng S; Mao Y; Wang X; Zhou M; Lu H; Zhao Q; Wang S
J Colloid Interface Sci; 2020 Feb; 559():51-64. PubMed ID: 31610305
[TBL] [Abstract][Full Text] [Related]
9. Fabrication of poly(ethylene glycol)-coated mesoporous nanocomposite ZnO@Fe
Alavi AS; Meshkini A
Eur J Pharm Sci; 2018 Mar; 115():144-157. PubMed ID: 29353012
[TBL] [Abstract][Full Text] [Related]
10. Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy.
Li N; Wang Z; Zhang Y; Zhang K; Xie J; Liu Y; Li W; Feng N
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):921-935. PubMed ID: 29790797
[TBL] [Abstract][Full Text] [Related]
11. Functionalized Mesoporous Silica Nanoparticles for Drug-Delivery to Multidrug-Resistant Cancer Cells.
Igaz N; Bélteky P; Kovács D; Papp C; Rónavári A; Szabó D; Gácser A; Kónya Z; Kiricsi M
Int J Nanomedicine; 2022; 17():3079-3096. PubMed ID: 35859731
[TBL] [Abstract][Full Text] [Related]
12. Decapeptide functionalized targeted mesoporous silica nanoparticles with doxorubicin exhibit enhanced apoptotic effect in breast and prostate cancer cells.
Tambe P; Kumar P; Paknikar KM; Gajbhiye V
Int J Nanomedicine; 2018; 13():7669-7680. PubMed ID: 30538451
[TBL] [Abstract][Full Text] [Related]
13. YSA-conjugated mesoporous silica nanoparticles effectively target EphA2-overexpressing breast cancer cells.
Liu Z; Tao Z; Zhang Q; Wan S; Zhang F; Zhang Y; Wu G; Wang J
Cancer Chemother Pharmacol; 2018 Apr; 81(4):687-695. PubMed ID: 29392452
[TBL] [Abstract][Full Text] [Related]
14. Green synthesized-zinc oxide nanoparticles, the strong apoptosis inducer as an exclusive antitumor agent in murine breast tumor model and human breast cancer cell lines (MCF7).
Mahdizadeh R; Homayouni-Tabrizi M; Neamati A; Seyedi SMR; Tavakkol Afshari HS
J Cell Biochem; 2019 Oct; 120(10):17984-17993. PubMed ID: 31172567
[TBL] [Abstract][Full Text] [Related]
15. Smart MSN-Drug-Delivery System for Tumor Cell Targeting and Tumor Microenvironment Release.
Dong JH; Ma Y; Li R; Zhang WT; Zhang MQ; Meng FN; Ding K; Jiang HT; Gong YK
ACS Appl Mater Interfaces; 2021 Sep; 13(36):42522-42532. PubMed ID: 34463488
[TBL] [Abstract][Full Text] [Related]
16. The eradication of breast cancer cells and stem cells by 8-hydroxyquinoline-loaded hyaluronan modified mesoporous silica nanoparticle-supported lipid bilayers containing docetaxel.
Wang D; Huang J; Wang X; Yu Y; Zhang H; Chen Y; Liu J; Sun Z; Zou H; Sun D; Zhou G; Zhang G; Lu Y; Zhong Y
Biomaterials; 2013 Oct; 34(31):7662-73. PubMed ID: 23859657
[TBL] [Abstract][Full Text] [Related]
17. Ameliorative effect of zinc oxide-chitosan conjugates on the anticancer activity of cisplatin: Approach for breast cancer treatment.
Mohamed SY; Elshoky HA; El-Sayed NM; Fahmy HM; Ali MA
Int J Biol Macromol; 2024 Feb; 257(Pt 1):128597. PubMed ID: 38056740
[TBL] [Abstract][Full Text] [Related]
18. Poly(amino acid)/ZnO/mesoporous silica nanoparticle based complex drug delivery system with a charge-reversal property for cancer therapy.
Kuang Y; Chen H; Chen Z; Wan L; Liu J; Xu Z; Chen X; Jiang B; Li C
Colloids Surf B Biointerfaces; 2019 Sep; 181():461-469. PubMed ID: 31176118
[TBL] [Abstract][Full Text] [Related]
19. Correlative Light-Electron Microscopy Shows RGD-Targeted ZnO Nanoparticles Dissolve in the Intracellular Environment of Triple Negative Breast Cancer Cells and Cause Apoptosis with Intratumor Heterogeneity.
Othman BA; Greenwood C; Abuelela AF; Bharath AA; Chen S; Theodorou I; Douglas T; Uchida M; Ryan M; Merzaban JS; Porter AE
Adv Healthc Mater; 2016 Jun; 5(11):1310-25. PubMed ID: 27111660
[TBL] [Abstract][Full Text] [Related]
20. Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells.
Sarkar A; Ghosh S; Chowdhury S; Pandey B; Sil PC
Biochim Biophys Acta; 2016 Oct; 1860(10):2065-75. PubMed ID: 27392941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
